[2] Hartmann TN，Burger JA，Glodek A，et al.CXCR4 chemokinereceptor and integrin signaling co-operate in mediating adhesionand chemoresistance in small cell lung cancer(SCLC) cells[J].Oncogene，2005，24(27) : 4462 - 4471.
[2] Kang H，Mansel RE， Jiang WG.Genetic manipulation of stromalcell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells[J].Int J Oncol，2005，26(5) : 1429 - 1434.
[3] Nagasawa T，Kikutani H，Kishimoto T.Molecular cloning andstructure of a pre-B-cell growth-stimulating factor[J].Proc NatlAcad Sci USA，1994，91(6) : 2305 - 2309.
[4] Zou YR，Kottmann AH，Kuroda M，et al.Function of thechemokine receptor CXCR4 in haematopoiesis and in cerebellardevelopment[J].Nature，1998，393(6685) : 595 - 599.
[5] Hernndez-Lpez C，Varas A，Sacedn R，et al.The CXCL12/CXCR4 pair in aged human thymus[J].Neuroimmunomodulation，2010， 17(3) : 217 - 220.
[6] Babcock GJ，Farzan M，Sodroski J，et al.Ligand-independentdimerization of CXCR4，a principal HIV-1 coreceptor[J].J BiolChem，2003，278(5) : 3378 - 3385.
[7] Sun YX，Schneider A，Jung Y，et al.Skeletal localization andneutralization of the CXCL12 (CXCL12 )/CXCR4 axis blocksprostate cancer metastasis and growth in osseous sites in vivo[J].J Bone Miner Res，2005，20(2) : 318 - 329.
[8] Katayama A，Ogino T，Bandoh N， et al.Expression of CXCR4 andits down-regulation by IFN- in head and neck squamous cellcarcinoma[J].Clin Cancer Res，2005，11(8) : 2937 - 2946.
[9] Dziembowska M，Tham TN，Lau P，et al.A role for CXCR4signaling in survival and migration of neural and oligodendrocyteprecursors[J].Glia，2005，50(3) : 258 - 269.
[10] Mellado M，Rodrguez-Frade JM，Maes S，et al.Chemokinesignaling and functional responses: the role of receptordimerization and TK pathway activation[J].Annu Rev Immunol，2001，19: 397 - 421.
[11] Rubin JB.Chemokine signaling in cancer: one hump or two[J].Semin Cancer Biol，2009，19(2) : 116 - 122.
[12] Ward SG.T lymphocytes on the move: chemokines，PI 3-kinaseand beyond[J].Trends Immunol，2006，27(2) : 80 - 87.
[13] Zhang XF，Wang JF，Matczak E， et al.Janus kinase 2 is involvedin stromal cell-derived factor-1-induced tyrosine phosphorylationof focal adhesion proteins and migration of hematopoieticprogenitor cells[J].Blood，2001，97(11) : 3342 - 3348.
[14] Bendall LJ，Baraz R，Juarez J，et al.Defective p38 mitogenactivatedprotein kinase signaling impairs chemotaxic but notproliferative responses to stromal-derived factor-1 in acutelymphoblastic leukemia[J].Cancer Res，2005，65 (8) : 3290 -3298.
[15] Barbero S，Bonavia R，Bajetto A， et al.Stromal cell-derived factor1 stimulates human glioblastoma cell growth through theactivation of both extracellular signal-regulated kinases 1/2 andAkt[J].Cancer Res，2003，63(8) : 1969 - 1974.
[16] Vlahakis SR，Villasis-Keever A，Gomez T， et al.G protein-coupledchemokine receptors induce both survival and apoptotic signalingpathways[J].J Immunol，2002，169(10) : 5546 - 5554.
[17] Suzuki Y，Rahman M，Mitsuya H.Diverse transcriptional responseof CD4 + T cells to stromal cell-derived factor (SDF ) -1: cellsurvival promotion and priming effects of SDF-1 on CD4 + T cells[J].J Immunol，2001，167(6) : 3064 - 3073.
[18] Ngo HT，Leleu X，Lee J，et al.SDF-1/CXCR4 and VLA-4interaction regulates homing in Waldenstrom macroglobulinemia[J].Blood，2008，112(1) : 150 - 158.
[19] Balabanian K，Levoye A，Klemm L， et al.Leukocyte analysis fromWHIM syndrome patients reveals a pivotal role for GRK3 inCXCR4 signaling[J].J Clin Invest，2008，118(3) : 1074 - 1084.
[20] Fischer L，Korfel A，Pfeiffer S，et al.CXCL13 and CXCL12 incentral nervous system lymphoma patients[J].Clin Cancer Res，2009，15(19) : 5968 - 5973.
[21] Sauv K，Lepage J，Sanchez M， et al.Positive feedback activationof estrogen receptors by the CXCL12-CXCR4 pathway[J].CancerRes，2009，69(14) : 5793 - 5800.
[22] Singh S，Bond VC，Powell M，et al.CXCR4-gp 120-IIIBinteractions induce caspase-mediated apoptosis of prostate cancercells and inhibit tumor growth[J].Mol Cancer Ther，2009，8(1) : 178 - 184.
[23] Gassmann P，Haier J，Schluter K， et al.CXCR4 regulates the earlyextravasation of metastatic tumor cells in vivo[J].Neoplasia，2009，11(7) : 651 - 661.
[24] Kwong J，Kulbe H，Wong D， et al.An antagonist of the chemokinereceptor CXCR4 induces mitotic catastrophe in ovarian cancercells[J].Mol Cancer Ther，2009，8(7) : 1893 - 1905.
[25] Muller A，Homey B，Soto H，et al.Involvement of chemokinereceptors in breast cancer metastasis[J].Nature，2001，410(6824) : 50 - 56.
[26] Salvucci O，Bouchard A，Baccarelli A， et al.The role of CXCR4receptor expression in breast cancer: a large tissue microarraystudy[J].Breast Cancer Res Treat，2006，97(3) : 275 - 283.
[27] Kang H，Mansel RE， Jiang WG.Genetic manipulation of stromalcell derived factor-1 attests the piotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells[J].Int Oncol，2005，26(5) : 1429 - 1434.
[28] Sutton A，Friand V，Brule-Donneger S， et al.Stromal cell-derivedfactor-l/chemokine(C-X-C motif ) ligand 12 stimulates humanhepatoma cell growth，migration，and invasion[J].Mol CancerRes，2007，5(1) : 21 - 33.
[29] Kang H，Watkins G，Douglas-Jones A， et al.The elevated level ofCXCR4 is correlated with nodal metastasis of human breast cancer[J].Breast，2005，14(5) : 360 - 367.
[30] Castellone MD，Guarino V，De Falco V，et al.Functionalexpression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroidcarcinomas[J].Oncogene，2004，23(35) : 5958 - 5967.
[31] Schimanski CC，Bahre R，Gockel I，et al.Dissemination ofhepatocellular caranoma is mediated via chemokine receptorCXCR4[J].Br J Cancer，2006，95(2) : 210 - 217.
[32] Tamamura H，Tsutsumi H，Fujii N.The chemokine receptorCXCR4 as a therapeutic target for several diseases[J].Mini RevMed Chem，2006，6(9) : 989 - 995.
[33] Yang QL，Ding YX，Chen CJ， et al.Suppression of murine breastcancer metastasis by selective inhibition of CXCR4 by syntheticpolypeptide derived from viral macrophage inflammatory proteinⅡ[J].Huazhong Univ Sci Technol，2011，31(4) : 497 - 503.
[34] Redjal N，Chan JA，Segal RA， et al.CXCR4 inhibition synergizeswith cytotoxic chemotherapy in gliomas[J].Clin Cancer Res，2006，12(22) : 6765 - 6771.